Genmab A/S
ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA
Last updated:
Abstract:
Isolated human monoclonal antibodies which bind to human CD38, and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Status:
Application
Type:
Utility
Filling date:
18 Feb 2020
Issue date:
10 Sep 2020